| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
Endocrine Unit, Middlesex Hospital, London.
We investigated thyroid function in 119 survivors of treatment for brain tumours not involving the hypothalamo-pituitary region. Cranial irradiation did not effect thyroid function but 11 of 47 children (23%) who had spinal irradiation had raised concentrations of thyroid stimulating hormone. Chemotherapy further increased the incidence of thyroid dysfunction: two of four patients who had cranial irradiation and chemotherapy and 20 of 29 patients (69%) who had spinal irradiation and chemotherapy had increased thyroid stimulating hormone concentrations. Only six patients with raised thyroid stimulating hormone concentrations had low serum thyroxine concentrations. Four children had secondary hypothyroidism. Thyroid function should be monitored in children who have received chemotherapy or radiotherapy. A rise in thyroid stimulating hormone concentrations is the most sensitive indicator of thyroid dysfunction. Children with raised thyroid stimulating hormone concentrations should be treated with thyroxine.
This article has been cited by other articles:
|
|
 |
|
  K. S. Bull, H. A. Spoudeas, G. Yadegarfar, and C. R. Kennedy Reduction of Health Status 7 Years After Addition of Chemotherapy to Craniospinal Irradiation for Medulloblastoma: A Follow-Up Study in PNET 3 Trial Survivors on Behalf of the CCLG (formerly UKCCSG) J. Clin. Oncol., September 20, 2007; 25(27): 4239 - 4245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H K Gleeson and S M Shalet The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours Endocr. Relat. Cancer, December 1, 2004; 11(4): 589 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Gurney, K. K. Ness, M. Stovall, S. Wolden, J. A. Punyko, J. P. Neglia, A. C. Mertens, R. J. Packer, L. L. Robison, and C. A. Sklar Final Height and Body Mass Index among Adult Survivors of Childhood Brain Cancer: Childhood Cancer Survivor Study J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4731 - 4739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. van Santen, T. Vulsma, M. G. Dijkgraaf, R. M. E. Blumer, R. Heinen, M. W. M. Jaspers, M. M. Geenen, M. O. Offringa, J. J. M. De Vijlder, and C. van den Bos No Damaging Effect of Chemotherapy in Addition to Radiotherapy on the Thyroid Axis in Young Adult Survivors of Childhood Cancer J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3657 - 3663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schmiegelow, U. Feldt-Rasmussen, A. K. Rasmussen, M. Lange, H. S. Poulsen, and J. Muller Assessment of the Hypothalamo-Pituitary-Adrenal Axis in Patients Treated with Radiotherapy and Chemotherapy for Childhood Brain Tumor J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3149 - 3154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schmiegelow, U. Feldt-Rasmussen, A. K. Rasmussen, H. S. Poulsen, and J. Muller A Population-Based Study of Thyroid Function after Radiotherapy and Chemotherapy for a Childhood Brain Tumor J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 136 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Diagnosis of Hidden Central Hypothyroidism in Survivors of Childhood Cancer J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4472 - 4479. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. S. Constine, P. D. Woolf, D. Cann, G. Mick, K. McCormick, R. F. Raubertas, and P. Rubin Hypothalamic-Pituitary Dysfunction after Radiation for Brain Tumors N. Engl. J. Med., January 14, 1993; 328(2): 87 - 94. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |
